124 related articles for article (PubMed ID: 9321758)
1. Oculocutaneous albinism in an isolated Tonga community in Zimbabwe.
Lund PM; Puri N; Durham-Pierre D; King RA; Brilliant MH
J Med Genet; 1997 Sep; 34(9):733-5. PubMed ID: 9321758
[TBL] [Abstract][Full Text] [Related]
2. Type 2 oculocutaneous albinism (OCA2) in Zimbabwe and Cameroon: distribution of the 2.7-kb deletion allele of the P gene.
Puri N; Durbam-Pierre D; Aquaron R; Lund PM; King RA; Brilliant MH
Hum Genet; 1997 Oct; 100(5-6):651-6. PubMed ID: 9341887
[TBL] [Abstract][Full Text] [Related]
3. Oculocutaneous albinism among schoolchildren in Harare, Zimbabwe.
Kagore F; Lund PM
J Med Genet; 1995 Nov; 32(11):859-61. PubMed ID: 8592327
[TBL] [Abstract][Full Text] [Related]
4. Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa.
Kerr R; Stevens G; Manga P; Salm S; John P; Haw T; Ramsay M
Hum Mutat; 2000; 15(2):166-72. PubMed ID: 10649493
[TBL] [Abstract][Full Text] [Related]
5. A 122.5-kilobase deletion of the P gene underlies the high prevalence of oculocutaneous albinism type 2 in the Navajo population.
Yi Z; Garrison N; Cohen-Barak O; Karafet TM; King RA; Erickson RP; Hammer MF; Brilliant MH
Am J Hum Genet; 2003 Jan; 72(1):62-72. PubMed ID: 12469324
[TBL] [Abstract][Full Text] [Related]
6. Oculocutaneous albinism in a rural community of South Africa: a population genetic study.
Lund PM; Maluleke TG; Gaigher I; Gaigher MJ
Ann Hum Biol; 2007; 34(4):493-7. PubMed ID: 17620156
[TBL] [Abstract][Full Text] [Related]
7. Albinism in Africa as a public health issue.
Hong ES; Zeeb H; Repacholi MH
BMC Public Health; 2006 Aug; 6():212. PubMed ID: 16916463
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic characterization of Congolese patients with oculocutaneous albinism.
Laetitia MM; Veronique K; Mamy NZ; Cathy SM; Aimé L; Race V; Prosper LT; Devriendt K
Eur J Med Genet; 2022 Nov; 65(11):104611. PubMed ID: 36116698
[TBL] [Abstract][Full Text] [Related]
9. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico.
Santiago Borrero PJ; Rodríguez-Pérez Y; Renta JY; Izquierdo NJ; Del Fierro L; Muñoz D; Molina NL; Ramírez S; Pagán-Mercado G; Ortíz I; Rivera-Caragol E; Spritz RA; Cadilla CL
J Invest Dermatol; 2006 Jan; 126(1):85-90. PubMed ID: 16417222
[TBL] [Abstract][Full Text] [Related]
10. Estimation of carrier frequency of a 2.7 kb deletion allele of the P gene associated with OCA2 in African-Americans.
Durham-Pierre D; King RA; Naber JM; Laken S; Brilliant MH
Hum Mutat; 1996; 7(4):370-3. PubMed ID: 8723691
[No Abstract] [Full Text] [Related]
11. Novel compound heterozygous mutations in OCA2 gene associated with non-syndromic oculocutaneous albinism in a Chinese Han patient: a case report.
Wang H; Wan Y; Yang Y; Li H; Mao L; Gao S; Xu J; Wang J
BMC Med Genet; 2019 Jul; 20(1):130. PubMed ID: 31345173
[TBL] [Abstract][Full Text] [Related]
12. Novel mutations of the P gene in type II oculocutaneous albinism (OCA2).
Spritz RA; Lee ST; Fukai K; Brondum-Nielsen K; Chitayat D; Lipson MH; Musarella MA; Rosenmann A; Weleber RG
Hum Mutat; 1997; 10(2):175-7. PubMed ID: 9259203
[No Abstract] [Full Text] [Related]
13. A novel P gene missense mutation in a Japanese patient with oculocutaneous albinism type II (OCA2).
Kato A; Fukai K; Oiso N; Hosomi N; Saitoh S; Wada T; Shimizu H; Ishii M
J Dermatol Sci; 2003 May; 31(3):189-92. PubMed ID: 12727022
[TBL] [Abstract][Full Text] [Related]
14. Six novel P gene mutations and oculocutaneous albinism type 2 frequency in Japanese albino patients.
Suzuki T; Miyamura Y; Matsunaga J; Shimizu H; Kawachi Y; Ohyama N; Ishikawa O; Ishikawa T; Terao H; Tomita Y
J Invest Dermatol; 2003 May; 120(5):781-3. PubMed ID: 12713581
[TBL] [Abstract][Full Text] [Related]
15. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
[TBL] [Abstract][Full Text] [Related]
16. Oculocutaneous albinism (OCA2) in sub-Saharan Africa: distribution of the common 2.7-kb P gene deletion mutation.
Stevens G; Ramsay M; Jenkins T
Hum Genet; 1997 Apr; 99(4):523-7. PubMed ID: 9099845
[TBL] [Abstract][Full Text] [Related]
17. Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism.
Grønskov K; Ek J; Sand A; Scheller R; Bygum A; Brixen K; Brondum-Nielsen K; Rosenberg T
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1058-64. PubMed ID: 19060277
[TBL] [Abstract][Full Text] [Related]
18. Oculocutaneous albinism in southern Africa: population structure, health and genetic care.
Lund PM
Ann Hum Biol; 2005; 32(2):168-73. PubMed ID: 16096213
[TBL] [Abstract][Full Text] [Related]
19. Distribution of oculocutaneous albinism in Zimbabwe.
Lund PM
J Med Genet; 1996 Aug; 33(8):641-4. PubMed ID: 8863154
[TBL] [Abstract][Full Text] [Related]
20. Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan.
Inagaki K; Suzuki T; Shimizu H; Ishii N; Umezawa Y; Tada J; Kikuchi N; Takata M; Takamori K; Kishibe M; Tanaka M; Miyamura Y; Ito S; Tomita Y
Am J Hum Genet; 2004 Mar; 74(3):466-71. PubMed ID: 14961451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
